Sergio Coffa

Array ( [id] => 8671744 [patent_doc_number] => 20130046283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'METHODS AND INTRAVASCULAR TREATMENT DEVICES FOR TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 13/464907 [patent_app_country] => US [patent_app_date] => 2012-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13700 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13464907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586839 [patent_doc_number] => 20130005660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'Plasma Activation of Biological Materials for Surface Modification' [patent_app_type] => utility [patent_app_number] => 13/458432 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 7644 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10069509 [patent_doc_number] => 09107845 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Synthetic platelets' [patent_app_type] => utility [patent_app_number] => 14/111650 [patent_app_country] => US [patent_app_date] => 2012-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 13840 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14198943 [patent_doc_number] => 10266565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-23 [patent_title] => Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use [patent_app_type] => utility [patent_app_number] => 14/111540 [patent_app_country] => US [patent_app_date] => 2012-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 38 [patent_no_of_words] => 42289 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16261245 [patent_doc_number] => 10752664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-25 [patent_title] => Method of treating or ameliorating metabolic disorders using growth differentiation factor 15 (GDF-15) [patent_app_type] => utility [patent_app_number] => 14/009790 [patent_app_country] => US [patent_app_date] => 2012-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 71 [patent_no_of_words] => 14671 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8885050 [patent_doc_number] => 20130158234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'SPECIFIC BINDING AGENTS OF HUMAN ANGIOPOIETIN-2' [patent_app_type] => utility [patent_app_number] => 13/435810 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 48581 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435810 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476718 [patent_doc_number] => 20120276124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'MAYTANSINOIDS AND THE USE OF SAID MAYTANSINOIDS TO PREPARE CONJUGATES WITH AN ANTIBODY' [patent_app_type] => utility [patent_app_number] => 13/434363 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17381 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13434363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9448972 [patent_doc_number] => 20140120141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'PEPTIDES USEFUL IN THE TREATMENT AND CARE OF THE SKIN AND MUCOUS MEMBRANES AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/007072 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22862 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9383500 [patent_doc_number] => 20140086981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'PGC-1ALPHA-MODULATING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/006981 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26752 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10071707 [patent_doc_number] => 09110059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-18 [patent_title] => 'Bio-pin' [patent_app_type] => utility [patent_app_number] => 14/005047 [patent_app_country] => US [patent_app_date] => 2012-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 11526 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9362727 [patent_doc_number] => 20140072600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'FACTOR XII INHIBITORS FOR THE ADMINISTRATION WITH MEDICAL PROCEDURES COMPRISING CONTACT WITH ARTIFICIAL SURFACES' [patent_app_type] => utility [patent_app_number] => 14/004066 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13794 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10103839 [patent_doc_number] => 09139612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Active agent prodrugs with heterocyclic linkers' [patent_app_type] => utility [patent_app_number] => 14/000594 [patent_app_country] => US [patent_app_date] => 2012-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 30 [patent_no_of_words] => 69885 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389319 [patent_doc_number] => 08685916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'Opioid prodrugs with heterocyclic linkers' [patent_app_type] => utility [patent_app_number] => 13/415790 [patent_app_country] => US [patent_app_date] => 2012-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 30 [patent_no_of_words] => 59921 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13415790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307095 [patent_doc_number] => 20140045769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'HYDROGEN BOND SURROGATE MACROCYCLES AS MODULATORS OF RAS' [patent_app_type] => utility [patent_app_number] => 14/003219 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12207 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9616771 [patent_doc_number] => 20140206629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'Stromal Derived Factor Inhibition And CXCR4 Blockade' [patent_app_type] => utility [patent_app_number] => 13/985415 [patent_app_country] => US [patent_app_date] => 2012-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13161 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9223515 [patent_doc_number] => 20140018290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'LEPTIN DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/979773 [patent_app_country] => US [patent_app_date] => 2012-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13456 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8277355 [patent_doc_number] => 20120171229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'SYNTHETIC NANOCARRIERS WITH REACTIVE GROUPS THAT RELEASE BIOLOGICALLY ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 13/341020 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21153 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13341020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9331286 [patent_doc_number] => 20140058068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'Novel GH-RH analogs with potent agonistic effects' [patent_app_type] => utility [patent_app_number] => 13/332624 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45723 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13332624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9197723 [patent_doc_number] => 20130337038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'CHIMERIC FIBRONECTIN MATRIX MIMETICS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/994179 [patent_app_country] => US [patent_app_date] => 2011-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25865 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10920382 [patent_doc_number] => 20140323403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'HEMOGLOBIN COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/992339 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4728 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992339 [rel_patent_id] =>[rel_patent_doc_number] =>)